Sign in Register

Drug class

Irritable Bowel Syndrome Agents

Irritable bowel syndrome agents constitute a therapeutic class of gastrointestinal medications designed to manage the abdominal pain, discomfort, and altered bowel motility characteristic of irritable bowel syndrome. Read more about Irritable Bowel Syndrome Agents

50 drugs in this class 43 manufacturers

Related classes & indications

Proton Pump InhibitorsGastrointestinal · 219 prescription drugs Histamine-2 Receptor Antagonists (H2 Antagonists)Gastrointestinal · 78 prescription drugs Chronic Idiopathic ConstipationTop indication · 37 prescription drugs

Showing 37–45 of 50 drugs

Sort

PRUCALOPRIDE (prucalopride succinate)

GI STIMULANTS · CHRONIC IDIOPATHIC CONSTIPATION

NOVADOZ PHARMAC

PRUCALOPRIDE (prucalopride succinate)

GI STIMULANTS · CHRONIC IDIOPATHIC CONSTIPATION

Amneal Pharmaceuticals

PRUCALOPRIDE (prucalopride succinate)

GI STIMULANTS · CHRONIC IDIOPATHIC CONSTIPATION

SANDOZ

PRUCALOPRIDE (prucalopride succinate)

GI STIMULANTS · CHRONIC IDIOPATHIC CONSTIPATION

Hikma Pharmaceuticals USA

LUBIPROSTONE

IRRITABLE BOWEL SYNDROME AGENTS · CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME ·+2

NORTHSTAR RX LL

PRUCALOPRIDE (prucalopride succinate)

GI STIMULANTS · CHRONIC IDIOPATHIC CONSTIPATION

Pfizer Laboratories

PRUCALOPRIDE (prucalopride succinate)

GI STIMULANTS · CHRONIC IDIOPATHIC CONSTIPATION

AVKARE

ALOSETRON HCL

IRRITABLE BOWEL SYNDROME AGENTS · DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME

AVKARE

ALOSETRON HCL

IRRITABLE BOWEL SYNDROME AGENTS · DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME

EYWA PHARMA INC

Filter & compare in the drug finder → Opens the drug finder with Irritable Bowel Syndrome Agents preselected. Add indication or manufacturer filters there.

About Irritable Bowel Syndrome Agents.

Irritable bowel syndrome agents constitute a therapeutic class of gastrointestinal medications designed to manage the abdominal pain, discomfort, and altered bowel motility characteristic of irritable bowel syndrome.

Rather than sharing a single mechanism of action, the class encompasses diverse pharmacologic subclasses tailored to specific disease subtypes, including chloride channel activators, guanylate cyclase-C agonists, and sodium-hydrogen exchanger inhibitors that stimulate intestinal fluid secretion to relieve constipation, as well as serotonin 5-HT3 receptor antagonists and mixed opioid receptor modulators that slow transit and reduce visceral hypersensitivity to control diarrhea.

Consequently, these agents are indicated for the management of irritable bowel syndrome with constipation (IBS-C) and irritable bowel syndrome with diarrhea (IBS-D) in adult patients.

fda.gov
Irritable bowel syndrome agents constitute a therapeutic class of gastrointestinal medications designed to manage the abdominal pain, discomfort, and altered bowel motility characteristic of irritable bowel syndrome
nih.gov
Irritable bowel syndrome agents constitute a therapeutic class of gastrointestinal medications designed to manage the abdominal pain, discomfort, and altered bowel motility characteristic of irritable bowel syndrome Rather than sharing a single mechanism of action, the class encompasses diverse pharmacologic subclasses tailored to specific disease subtypes, including chloride channel activators, guanylate cyclase-C agonists, and sodium-hydrogen exchanger inhibitors that stimulate intestinal flui...
nih.gov
Rather than sharing a single mechanism of action, the class encompasses diverse pharmacologic subclasses tailored to specific disease subtypes, including chloride channel activators, guanylate cyclase-C agonists, and sodium-hydrogen exchanger inhibitors that stimulate intestinal fluid secretion to relieve constipation, as well as serotonin 5-HT3 receptor antagonists and mixed opioid receptor modulators that slow transit and reduce visceral hypersensitivity to control diarrhea Consequently, these...
nih.gov
Rather than sharing a single mechanism of action, the class encompasses diverse pharmacologic subclasses tailored to specific disease subtypes, including chloride channel activators, guanylate cyclase-C agonists, and sodium-hydrogen exchanger inhibitors that stimulate intestinal fluid secretion to relieve constipation, as well as serotonin 5-HT3 receptor antagonists and mixed opioid receptor modulators that slow transit and reduce visceral hypersensitivity to control diarrhea Consequently, these...
nih.gov
Rather than sharing a single mechanism of action, the class encompasses diverse pharmacologic subclasses tailored to specific disease subtypes, including chloride channel activators, guanylate cyclase-C agonists, and sodium-hydrogen exchanger inhibitors that stimulate intestinal fluid secretion to relieve constipation, as well as serotonin 5-HT3 receptor antagonists and mixed opioid receptor modulators that slow transit and reduce visceral hypersensitivity to control diarrhea Consequently, these...
nih.gov
Rather than sharing a single mechanism of action, the class encompasses diverse pharmacologic subclasses tailored to specific disease subtypes, including chloride channel activators, guanylate cyclase-C agonists, and sodium-hydrogen exchanger inhibitors that stimulate intestinal fluid secretion to relieve constipation, as well as serotonin 5-HT3 receptor antagonists and mixed opioid receptor modulators that slow transit and reduce visceral hypersensitivity to control diarrhea